EYPT vs KO · rev $1.2M vs P/E 25, rev $47.94B
Eyepoint Pharmaceuticals Inc (EYPT) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
EYPT currently screens at market cap $1.10B. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the EYPT and KO stock pages for the full models.
Not investment advice.